Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cindy Wu

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|December 8, 2006
Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimerasFrederick R Tejada, Peter I Nagy, Min Xu, et al.
Plos Pathogens|August 4, 2023
Effects of Capsular Polysaccharide amount on Pneumococcal-Host interactionsJiaqi Zhu, Annie R Abruzzo, Cindy Wu, et al.
Plastic and Reconstructive Surgery. Global Open|July 7, 2015
Identification of Best Practices for Resident Aesthetic Clinics in Plastic Surgery Training: The ACAPS National SurveyC Scott Hultman, Cindy Wu, Michael L Bentz, et al.
Journal of Medicinal Chemistry|September 19, 2003
Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disordersYang Cao, Minjia Zhang, Cindy Wu, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron VariantJinyan Liu, Abishek Chandrashekar, Daniel Sellers, et al.
Plos Pathogens|May 8, 2024
Impaired upper respiratory tract barrier function during postnatal development predisposes to invasive pneumococcal diseaseKristen L Lokken-Toyli, Surya D Aggarwal, Gavyn Chern Wei Bee, et al.
Nature|February 1, 2022
Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 OmicronJinyan Liu, Abishek Chandrashekar, Daniel Sellers, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Waning Immunity Against XBB.1.5 Following Bivalent mRNA BoostersNinaad Lasrado, Ai-Ris Y Collier, Jessica Miller, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Immunogenicity of the BA.5 Bivalent mRNA Vaccine BoostersAi-Ris Y Collier, Jessica Miller, Nicole P Hachmann, et al.
Science Advances|February 23, 2024
Waning immunity and IgG4 responses following bivalent mRNA boostingNinaad Lasrado, Ai-Ris Y Collier, Jessica Miller, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|December 8, 2006
Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimerasFrederick R Tejada, Peter I Nagy, Min Xu, et al.
Plos Pathogens|August 4, 2023
Effects of Capsular Polysaccharide amount on Pneumococcal-Host interactionsJiaqi Zhu, Annie R Abruzzo, Cindy Wu, et al.
Plastic and Reconstructive Surgery. Global Open|July 7, 2015
Identification of Best Practices for Resident Aesthetic Clinics in Plastic Surgery Training: The ACAPS National SurveyC Scott Hultman, Cindy Wu, Michael L Bentz, et al.
Journal of Medicinal Chemistry|September 19, 2003
Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disordersYang Cao, Minjia Zhang, Cindy Wu, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron VariantJinyan Liu, Abishek Chandrashekar, Daniel Sellers, et al.
Plos Pathogens|May 8, 2024
Impaired upper respiratory tract barrier function during postnatal development predisposes to invasive pneumococcal diseaseKristen L Lokken-Toyli, Surya D Aggarwal, Gavyn Chern Wei Bee, et al.
Nature|February 1, 2022
Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 OmicronJinyan Liu, Abishek Chandrashekar, Daniel Sellers, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Waning Immunity Against XBB.1.5 Following Bivalent mRNA BoostersNinaad Lasrado, Ai-Ris Y Collier, Jessica Miller, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Immunogenicity of the BA.5 Bivalent mRNA Vaccine BoostersAi-Ris Y Collier, Jessica Miller, Nicole P Hachmann, et al.
Science Advances|February 23, 2024
Waning immunity and IgG4 responses following bivalent mRNA boostingNinaad Lasrado, Ai-Ris Y Collier, Jessica Miller, et al.
Pageof 6